Skystar Bio-Pharmaceutical Company Stock
Equities
SKBI
US8308843007
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
Sales 2012 | 33.59M 45.97M | Sales 2013 | 42.48M 58.14M | Capitalization | 26.7M 36.55M |
---|---|---|---|---|---|
Net income 2012 | 6M 8.21M | Net income 2013 | 10M 13.69M | EV / Sales 2012 | 0.2 x |
Net cash position 2012 | 5.61M 7.68M | Net Debt 2013 | 2.5M 3.42M | EV / Sales 2013 | 0.69 x |
P/E ratio 2012 |
1.93
x | P/E ratio 2013 |
2.56
x | Employees | - |
Yield 2012 * |
-
| Yield 2013 |
-
| Free-Float | 100% |
Members of the board | Title | Age | Since |
---|---|---|---|
Cheng Tun Qu
BRD | Director/Board Member | 58 | 08-06-30 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 0 | |
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |
- Stock Market
- Equities
- SKBI Stock